Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Thompson

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 13, 2013
Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelinesRichard K Valicenti, Ian Thompson, Peter Albertsen, et al.
BJU International|November 28, 2024
Utility of PSA free-to-total ratio for clinically significant prostate cancer in men with a PSA level of <4 ng/mLSamuel Sii, Nathan Papa, Ting Wai Yiu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2010
Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention TrialAshraful Hoque, Christine B Ambrosone, Cathee Till, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancerAnthony W Tolcher, Kim Chi, John Kuhn, et al.
BMC Medicine|February 12, 2014
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigenAndrew J Vickers, Daniel D Sjoberg, David Ulmert, et al.
Molecular Carcinogenesis|January 11, 2018
Circadian genes and risk of prostate cancer in the prostate cancer prevention trialLisa W Chu, Cathee Till, Baiyu Yang, et al.
Prostate Cancer and Prostatic Diseases|February 29, 2024
Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronelPrimo N Lara, Edward Mayerson, Erik Gertz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasiaJames R Marshall, Wael Sakr, David Wood, et al.
Plos One|December 2, 2025
The BrainWaves study of adolescent wellbeing and mental health: Methods development and pilot dataRyan D Parsons, Sarah Bauermeister, Julian Turner, et al.
Immunology|October 1, 2010
Phenotypic and functional characterization of a CD4(+) CD25(high) FOXP3(high) regulatory T-cell population in the dogDammy Pinheiro, Yogesh Singh, Charlotte R Grant, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|July 13, 2013
Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelinesRichard K Valicenti, Ian Thompson, Peter Albertsen, et al.
BJU International|November 28, 2024
Utility of PSA free-to-total ratio for clinically significant prostate cancer in men with a PSA level of <4 ng/mLSamuel Sii, Nathan Papa, Ting Wai Yiu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2010
Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention TrialAshraful Hoque, Christine B Ambrosone, Cathee Till, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancerAnthony W Tolcher, Kim Chi, John Kuhn, et al.
BMC Medicine|February 12, 2014
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigenAndrew J Vickers, Daniel D Sjoberg, David Ulmert, et al.
Molecular Carcinogenesis|January 11, 2018
Circadian genes and risk of prostate cancer in the prostate cancer prevention trialLisa W Chu, Cathee Till, Baiyu Yang, et al.
Prostate Cancer and Prostatic Diseases|February 29, 2024
Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronelPrimo N Lara, Edward Mayerson, Erik Gertz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasiaJames R Marshall, Wael Sakr, David Wood, et al.
Plos One|December 2, 2025
The BrainWaves study of adolescent wellbeing and mental health: Methods development and pilot dataRyan D Parsons, Sarah Bauermeister, Julian Turner, et al.
Immunology|October 1, 2010
Phenotypic and functional characterization of a CD4(+) CD25(high) FOXP3(high) regulatory T-cell population in the dogDammy Pinheiro, Yogesh Singh, Charlotte R Grant, et al.
Pageof 11